Method of treating depression
Patent
·
OSTI ID:1083791
Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K.sup.+ channel openers and .beta.-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Brookhaven Science Associates, LLC (Upton, NY)
- Patent Number(s):
- 8,415,344
- Application Number:
- 13/307,033
- OSTI ID:
- 1083791
- Country of Publication:
- United States
- Language:
- English
Treatment of behavioral disorders with &bgr;-lactam compounds
|
patent | September 2003 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
|
patent | December 2003 |
Treatment of arrhythmia by retinoids affecting signal transduction
|
patent | October 2009 |
Flupirtine in the treatment of fibromyalgia and related conditions
|
patent | August 2003 |
Similar Records
Method of treating depression
The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study
Identification of a Glycogen Synthase Kinase-3[beta] Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice
Patent
·
Tue Jan 24 00:00:00 EST 2012
·
OSTI ID:1083791
The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study
Journal Article
·
Thu Oct 19 00:00:00 EDT 2023
· Journal of Clinical Endocrinology and Metabolism
·
OSTI ID:1083791
+3 more
Identification of a Glycogen Synthase Kinase-3[beta] Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice
Journal Article
·
Wed May 02 00:00:00 EDT 2012
· ChemMedChem
·
OSTI ID:1083791
+6 more